x
Filter:
Filters applied
- EMAS Position Statements and Clinical Guides
- WomenRemove Women filter
Publication Date
Please choose a date range between 2015 and 2022.
Author
- Ceausu, Iuliana3
- Lambrinoudaki, Irene3
- Mueck, Alfred3
- Rees, Margaret3
- Stute, Petra3
- Armeni, Eleni2
- Depypere, Herman2
- Pérez-López, Faustino R2
- Senturk, Levent M2
- Simoncini, Tommaso2
- Stevenson, John C2
- Bretz, Silvia1
- Durmusoglu, Fatih1
- Erkkola, Risto1
- Fistonic, Ivan1
- Gambacciani, Marco1
- Geukes, Marije1
- Goulis, Dimitrios1
- Griffiths, Amanda1
- Hamoda, Haitham1
- Hartley, Caiomhe1
- Hirschberg, Angelica Lindén1
- Meczekalski, Blazej1
- Mendoza, Nicolas1
- Schouw, Yvonne Tvan der1
EMAS Position Statements and Clincial Guides
3 Results
- EMAS Consensus Statement
Menopause, wellbeing and health: A care pathway from the European Menopause and Andropause Society
MaturitasVol. 163p1–14Published online: May 12, 2022- Irene Lambrinoudaki
- Eleni Armeni
- Dimitrios Goulis
- Silvia Bretz
- Iuliana Ceausu
- Fatih Durmusoglu
- and others
Cited in Scopus: 8Life expectancy has considerably increased since 1970 [1], and now >50% of women are expected to break the 90-year barrier by 2030 [2]. Growing older rather than old means spending almost half of life after the menopause, challenging the concept of healthy ageing [3]. Iatrogenic menopause may be induced by cancer treatment or bilateral salpingo-oophorectomy for benign disease and may occur before the average age of natural menopause, which is around the age of 50 [4,5]. The sudden fall in estrogen levels with iatrogenic menopause may lead to rapid onset of vasomotor symptoms [4]. - Research Article
Maintaining postreproductive health: A care pathway from the European Menopause and Andropause Society (EMAS)
MaturitasVol. 89p63–72Published online: April 19, 2016- Eleni Armeni
- Irene Lambrinoudaki
- Iuliana Ceausu
- Herman Depypere
- Alfred Mueck
- Faustino R. Pérez-López
- and others
Cited in Scopus: 65This position statement from the European Menopause and Andropause Society (EMAS) provides a care pathway for the maintenance of women’s health during and after the menopause. It is designed for use by all those involved in women’s health. It covers assessment, screening for diseases in later life, treatment and follow-up. Strategies need to be optimised to maintain postreproductive health, in part because of increased longevity. They encompass optimising diet and lifestyle, menopausal hormone therapy and non-estrogen-based treatment options for climacteric symptoms and skeletal conservation, personalised to individual needs. - Research Article
EMAS recommendations for conditions in the workplace for menopausal women
MaturitasVol. 85p79–81Published online: December 16, 2015- Amanda Griffiths
- Iuliana Ceausu
- Herman Depypere
- Irene Lambrinoudaki
- Alfred Mueck
- Faustino R. Pérez-López
- and others
Cited in Scopus: 31Occupational health issues for older workers in general, and older women workers in particular, have often been ignored. Women form a large part of many workforces throughout Europe. The number of persons in employment in EU Member States rose between 2013 and 2014 by around 2.3 million, to 217.8 million in 2014 [1]. The employment rate for men was just over 70%, and for women, nearly 60%. A longer-term comparison shows that while the employment rate for men in 2014 was below its corresponding level ten years earlier, there was a marked increase in the proportion of women in employment.